Drug shared by addicts seems to protect against HIV brain dementia

Apr 15, 2010

To their surprise, researchers at Georgetown University Medical Center (GUMC) have discovered that morphine (a derivate of the opium poppy that is similar to heroin) protects rat neurons against HIV toxicity - a finding they say might help in the design of new neuroprotective therapies for patients with the infection.

The discovery, being presented at the annual meeting of the Society of NeuroImmune Pharmacology, also helps explain why a subset of people who are abusers and become infected with HIV through needle sharing don't develop HIV brain dementia. This brain disorder includes cognitive and motor abnormalities, anxiety and depression.

"We believe that morphine may be neuroprotective in a subset of people infected with HIV," says the study's lead investigator, Italo Mocchetti, PhD, Professor of neuroscience at GUMC. "That is not to say that people should use heroin to protect themselves - that makes no medical sense at all - but our findings gives us ideas about designing drugs that could be of benefit.

"Needless to say we were very surprised at the findings," he added. "We started with the opposite hypothesis - that heroin was going to destroy neurons in the brain and lead to HIV dementia."

The researchers conducted the study because they knew that a number of HIV-positive people are also heroin abusers, and because of that, some are at high risk of developing neurological complications from the infection. Others, however, never develop these , Mocchetti says.

Because little is known about the molecular mechanisms linking opiates and HIV , Mocchetti and his team conducted experiments in rats. They found that in the brain, morphine inhibited the toxic property of the HIV protein gp120 that mediates the infection of . With further investigation, they concluded that morphine induces production of the protein CCL5, which they discovered is released by astrocytes, a type of brain cell. CCL5 is known to activate factors that suppress HIV infection of human immune cells. "It is known to be important in blood, but we didn't know it is secreted in the brain," says Mocchetti. "Our hypothesis is that it is in the brain to prevent neurons from dying."

They say morphine blocked HIV from binding to CCR5 receptors it typically uses to enter and infect cells. The researchers believe CCL5 itself attached to those receptors, preventing the virus from using it. In this way, it prevented HIV-associated dementia. This effect, however, only worked in the M-trophic strain of , the strain that most people are first infected with. It did not work with the second T-trophic strain that often infects patients later.

"Ideally we can use this information to develop a morphine-like compound that does not have the typical dependency and tolerance issues that has," says Mocchetti.

Explore further: HIV infections double in Russia, ex-Soviet states

add to favorites email to friend print save as pdf

Related Stories

Neural progenitor cells as reservoirs for HIV in the brain

Mar 04, 2008

Impaired brain function is a prominent and still unsolved problem in AIDS . Shortly after an individual becomes infected with HIV, the virus can invade the brain and persist in this organ for life. Many HIV-infected individuals ...

HIV is a 'double hit' to the brain

Aug 15, 2007

New evidence reported in the August issue of Cell Stem Cell, a publication of Cell Press, offers a novel perspective on how the HIV/AIDS virus leads to learning and memory deficits, a condition known as HIV-associated dement ...

Scientists find another key to HIV success

Mar 22, 2006

Weill Cornell Medical College scientists say they've determined a protein produced by HIV infected cells prevents immune B cells from producing antibodies.

HIV-related brain problems are studied

Apr 27, 2006

Scripps Research Institute scientists have shed new light on the molecular basis of brain function problems associated with immune deficiency viruses.

Exhausted B cells fail to fight HIV

Jul 14, 2008

HIV tires out the cells that produce virus-fighting proteins known as antibodies, according to a human study that will be published online July 14 in the Journal of Experimental Medicine.

Recommended for you

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.